DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr |
What is the latest Total Liabilities ratio of DIVIS LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹17,717 Cr |
| Mar2024 | ₹15,937 Cr |
| Mar2023 | ₹14,863 Cr |
| Mar2022 | ₹14,619 Cr |
| Mar2021 | ₹11,387 Cr |
How is Total Liabilities of DIVIS LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17,717 Cr | 11.17 | |
| Mar2024 | ₹15,937 Cr | 7.23 | |
| Mar2023 | ₹14,863 Cr | 1.67 | |
| Mar2022 | ₹14,619 Cr | 28.39 | |
| Mar2021 | ₹11,387 Cr | - | |
Compare Total Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹159,614.6 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
| MANKIND PHARMA | ₹79,364.2 Cr | -4.4% | -3.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.5% |
-2.9% |
5.4% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses